Cargando…
Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients’ heart?
Fluoropyrimidines, such as capecitabine and 5-fluorouracil, may cause cardiac toxicity. In recent years, the incidence of this side effect has increased and it is expected to further rise due to the population aging and the disproportionate incidence of breast and gastrointestinal cancers in older i...
Autores principales: | Fontanella, Caterina, Aita, Marianna, Cinausero, Marika, Aprile, Giuseppe, Baldin, Maria Grazia, Dusi, Veronica, Lestuzzi, Chiara, Fasola, Gianpiero, Puglisi, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189715/ https://www.ncbi.nlm.nih.gov/pubmed/25302025 http://dx.doi.org/10.2147/OTT.S65653 |
Ejemplares similares
-
Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice
por: Dri, Arianna, et al.
Publicado: (2022) -
Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report
por: Fasola, Gianpiero, et al.
Publicado: (2006) -
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise
por: Lestuzzi, Chiara, et al.
Publicado: (2022) -
Drug waste minimisation and cost-containment in Medical Oncology: Two-year results of a feasibility study
por: Fasola, Gianpiero, et al.
Publicado: (2008) -
The puzzling clinical presentation of fluoropyrimidines cardiotoxicity
por: Cucciniello, Linda, et al.
Publicado: (2022)